Company intelligence / Profile preview

Shanghai Jenomed Biotech Co., Ltd.

Shanghai, Shanghai, Chinajenomed.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Shanghai Jenomed Biotech provides preclinical CRO services with expertise in recombinant protein production, animal modeling of cancers such as lung cancer and melanoma, as well as noninvasive isolation of circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) for biomarker discovery. The company has accumulated years of experience supporting early-stage drug development with these technologies.

Therapeutic areas: Oncology
Modalities: Recombinant proteinsctDNA/CTC analysisAnimal models for preclinical research
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Shanghai Jenomed Biotech Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Jenomed Biotech Co., Ltd..

Explore the full profile